Biochemical Genetics and Newborn Screening Flashcards

(41 cards)

1
Q

Inheritance of disorders affecting enzymatic proteins

A

typically autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

inheritance of disorders affecting structural proteins

A

often autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phenylketonuria (PKU) clinical presentation

A
  • autosomal recessive
  • normal neonate
  • DD beginning around 3-4 months
  • treated with diet low in protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mechanism of PKU

A
  • deficiency of enzyme: phenylalanine hydroxylase (PAH)
  • conversion of phenylalanine to tyrosine is blocked
  • buildup of PHE is neurotoxic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Methylmalonic Aciduria presentation

A
  • severe acidosis in first week of life

* treated with diet low in protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mechanism of methylmalonic aciduria

A
  • lack of enzyme activity: methylmalonyl-CoA mutase

* it converts methylmalonyl-CoA into succinyl-CoA (krebs cycle)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

test for PKU

A

phenylalanine elevated on plasma amino acid quantitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

test for methylmalonic aciduria

A

methylmalonic acid elevated on urine organic acid quantitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

important urea cycle defect

A
  • defect in pathway converting toxic ammonia to non-toxic urea
  • ornithine transcarbamylase (OTC) deficiency -> low citrulline
  • ^it is X LINKED
  • severe neurologic damage if not treated rapidly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

test for ornithine transcarbamylase (OTC) deficiency

A

low citrulline on plasma amino acid quantitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

other urea cycle defects

A
  • many enzymes; autosomal recessive
  • neurologic damage if not treated rapidly
  • plasma amino acid quantitation will have elevations of a diagnosic aa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

treatment for ornithine transcarbamylase (OTC) deficiency

A
  • diet low in protein

* ammonia scavenger medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hereditary fructose intolerance mechanism

A

•fructoaldolase (aldolase B) metabolized fructose to glucose (gluconeogenesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hereditary fructose intolerance presentation

A
  • key: NO fructose in breast milk, symptom onset with introduction of juices
  • ingestion of fructose acutely -> vomiting and hypoglycemia
  • chronic ingestion of fructose -> hepatomegaly and renal dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

diagnosis of hereditary fructose intolerance

A
  • clinical syspicion

* molecular analysis of aldolase B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

treatment of hereditary fructose intolerance

A

restricting fruit, vegetables, corn syrup, table sugar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

lesch-nyhan disease presentation

A
  • X linked recessive
  • neurologic dysfunction
  • hypotonic
  • self-mutilation behavior
18
Q

mechanism of lesch-nyhan disease

A
  • disorder of purine reclamation

* due to defect in hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity

19
Q

treatment of lesch-nyhan disease

A
  • low purine diet
  • allopurinol
  • medication for neurologic signs and symptoms
20
Q

diagnosis of lesch-nyhan disease

A
  • clinical suspicion
  • elevated uric acid
  • molecular analysis of HGPRT
21
Q

most common fatty acid oxidation disorder

A
  • medium chain acyl-CoA dehydrogenase (MCAD) deficiency

* it is autosomal recessive

22
Q

presentation of MCAD deficiency

A
  • child with lethargy and vomiting following fasting
  • classically presents with hypoketotic hypoglycemia
  • may be entirely asymptomatic
23
Q

other fatty acid oxidation disorders often involve

A

•cardiac and/or hepatic involvement

VLCAD, LCAD, SCAD, LCHAD, SCHAD

24
Q

testing for MCAD deficiency

and other fatty acid oxidation disorders

A
  • elevations of fatty acid oxidation intermediates on urine organic acid quantitation
  • acylcarnitine analysis
25
treatment of MCAD deficiency | and other fatty acid oxidation disorders
* avoidance of fasting | * rapid treatment of hypoglycemia (epinephrine?)
26
biotinidase defect
* results in biotin deficiency | * biotin important in carboxylation reaction
27
presentation of biotinidase defect
* alopecia * dermatitis * deafness * seizures * neurologic deterioration starting about 4-6 months of age
28
diagnosis of biotinidase defect
enzyme assay of biotinidase
29
treatment of biotinidase defect
biotin supplementation
30
Mechanism of Tay-Sachs disease
* autosomal recessive * β-hexosaminidase (A isoenzyme) mutation * lysosomal storage disease
31
clinical features of tay-sachs
hypotonia, spasticity, seizures, blindness
32
hunter syndrome mechanism
* x-linked recessive * iduronidate-2-sulfatase defect * accumulation of mucopolysaccharides such as dermatan and heparin sulfate
33
diagnosis of hunter syndrome
enzyme assay of iduronidate-2-sulfatase
34
treatment of hunter syndrome
* can be treated with enzyme replacement therapy (ERT) * an example name is elaprase * (enzyme being replaced is iduronidate-2-sulfatase
35
menke disease mechanism
* x-linked recessive * inability to absorb copper across intestinal epithelium * ^copper deficiency
36
testing for menke disease
* diagnosis suspected by low blood copper and ceruloplasmin | * molecular analysis of ATP7A gene
37
treatment for menke disease
* no real effective treatment | * copper histidinate infusion under investigation
38
presentation of menke disease
* severe neurodegenerative disorder beginning in first year of life * copper deficiency
39
Zellweger syndrome
* no peroxisomes formed * severe, fatal disease * diagnosis: elevation of very long chain fatty acids * no effective treatment
40
what are peroxisomes
cytoplasmic organelles with variety of biochemical functions: •peroxide metabolism •catabolism of very long chain fatty acids •catabolism of bile acids •synthesis of complex lipids (zellweger syndrome=peroxisomal disorder)
41
List of biochemical laboratory tests
* amino acid quantitation * urine organic acid quantitation * carnitine levels and acylcarnitine analysis * ammonia * lactic acid * urine mucopolysaccharides * very long chain fatty acids